BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B. The p63 protein isoform δnp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of mir-205. J BiolChem. 2013;288:3275-3288. [PMID: 23239884 DOI: 10.1074/jbc.m112.408104] [Cited by in Crossref: 93] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urol Oncol 2014;32:1108-15. [PMID: 25443274 DOI: 10.1016/j.urolonc.2013.10.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
2 Iyyanki T, Zhang B, Wang Q, Hou Y, Jin Q, Xu J, Yang H, Liu T, Wang X, Song F, Luan Y, Yamashita H, Chien R, Lyu H, Zhang L, Wang L, Warrick J, Raman JD, Meeks JJ, DeGraff DJ, Yue F. Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer. Genome Biol 2021;22:105. [PMID: 33858483 DOI: 10.1186/s13059-021-02325-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cañueto J, Cardeñoso-Álvarez E, García-Hernández JL, Galindo-Villardón P, Vicente-Galindo P, Vicente-Villardón JL, Alonso-López D, De Las Rivas J, Valero J, Moyano-Sanz E, Fernández-López E, Mao JH, Castellanos-Martín A, Román-Curto C, Pérez-Losada J. MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma. Br J Dermatol 2017;177:168-78. [PMID: 27943259 DOI: 10.1111/bjd.15236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bladen JC, Wang J, Sangaralingam A, Moosajee M, Fitchett C, Chelala C, Beaconsfield M, O'Toole EA, Philpott MP, Ezra DG. MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma. Sci Rep 2018;8:7531. [PMID: 29760516 DOI: 10.1038/s41598-018-25900-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yang G, Bondaruk J, Cogdell D, Wang Z, Lee S, Lee JG, Zhang S, Choi W, Wang Y, Liang Y, Wang G, Wang Y, Yao H, Dadhania V, Gao J, Logothetis C, Siefker-Radtke A, Kamat A, Dinney C, Theodorescu D, Kimmel M, Wei P, Guo CC, Weinstein JN, McConkey DJ, Czerniak B. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer. iScience 2020;23:101201. [PMID: 32521509 DOI: 10.1016/j.isci.2020.101201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Nekulova M, Holcakova J, Gu X, Hrabal V, Galtsidis S, Orzol P, Liu Y, Logotheti S, Zoumpourlis V, Nylander K, Coates PJ, Vojtesek B. ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells. BMC Cancer 2016;16:782. [PMID: 27724925 DOI: 10.1186/s12885-016-2808-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Wang HT, Lee HW, Weng MW, Liu Y, Huang WC, Lepor H, Wu XR, Tang MS. The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells. Elife 2021;10:e71184. [PMID: 34747697 DOI: 10.7554/eLife.71184] [Reference Citation Analysis]
8 Hasegawa T, Adachi R, Iwakata H, Takeno T, Sato K, Sakamaki T. ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer. FEBS Open Bio 2017;7:1154-65. [PMID: 28781955 DOI: 10.1002/2211-5463.12256] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
9 Knowles MA. FGFR3 – a Central Player in Bladder Cancer Pathogenesis? BLC 2020;6:403-23. [DOI: 10.3233/blc-200373] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Dong F, Xu T, Shen Y, Zhong S, Chen S, Ding Q, Shen Z. Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure. Oncotarget 2017;8:27547-68. [PMID: 28187437 DOI: 10.18632/oncotarget.15173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
11 Li Y, Moretto-Zita M, Leon-Garcia S, Parast MM. p63 inhibits extravillous trophoblast migration and maintains cells in a cytotrophoblast stem cell-like state. Am J Pathol 2014;184:3332-43. [PMID: 25307348 DOI: 10.1016/j.ajpath.2014.08.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
12 Assefnia S, Kang K, Groeneveld S, Yamaji D, Dabydeen S, Alamri A, Liu X, Hennighausen L, Furth PA. Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer. Endocr Relat Cancer 2014;21:443-57. [PMID: 24692510 DOI: 10.1530/ERC-14-0032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
13 Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 2015;15:25-41. [PMID: 25533674 DOI: 10.1038/nrc3817] [Cited by in Crossref: 557] [Cited by in F6Publishing: 523] [Article Influence: 79.6] [Reference Citation Analysis]
14 Yun SJ, Kim WJ. Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target. Korean J Urol 2013;54:645-50. [PMID: 24175036 DOI: 10.4111/kju.2013.54.10.645] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
15 Heubach J, Monsior J, Deenen R, Niegisch G, Szarvas T, Niedworok C, Schulz WA, Hoffmann MJ. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells. Mol Cancer 2015;14:108. [PMID: 25994132 DOI: 10.1186/s12943-015-0371-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 6.9] [Reference Citation Analysis]
16 Mattioli C, Pianigiani G, Pagani F. A competitive regulatory mechanism discriminates between juxtaposed splice sites and pri-miRNA structures. Nucleic Acids Res 2013;41:8680-91. [PMID: 23863840 DOI: 10.1093/nar/gkt614] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
17 Zhang JY, Sun MY, Song NH, Deng ZL, Xue CY, Yang J. Prognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studies. BMJ Open 2015;5:e006244. [PMID: 25613953 DOI: 10.1136/bmjopen-2014-006244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
18 Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, Chira S, Budisan L, Jurj A, Ciocan C, Magdo L, Irimie A, Dobrota F, Petrut B, Berindan-Neagoe I. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. J Exp Clin Cancer Res 2019;38:433. [PMID: 31665050 DOI: 10.1186/s13046-019-1406-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
19 Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer. World J Gastroenterol 2013; 19(18): 2781-2792 [PMID: 23687415 DOI: 10.3748/wjg.v19.i18.2781] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
20 Iwanicki MP, Chen HY, Iavarone C, Zervantonakis IK, Muranen T, Novak M, Ince TA, Drapkin R, Brugge JS. Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. JCI Insight 2016;1:86829. [PMID: 27482544 DOI: 10.1172/jci.insight.86829] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
21 Rodriguez Calleja L, Jacques C, Lamoureux F, Baud'huin M, Tellez Gabriel M, Quillard T, Sahay D, Perrot P, Amiaud J, Charrier C, Brion R, Lecanda F, Verrecchia F, Heymann D, Ellisen LW, Ory B. ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis. Cancer Res 2016;76:3236-51. [PMID: 26988989 DOI: 10.1158/0008-5472.CAN-15-2317] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
22 Monteiro-Reis S, Lobo J, Henrique R, Jerónimo C. Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer. Int J Mol Sci 2019;20:E297. [PMID: 30642115 DOI: 10.3390/ijms20020297] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
23 Yoshida T, Okuyama H, Nakayama M, Endo H, Tomita Y, Nonomura N, Nishimura K, Inoue M. Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters. Neoplasia 2015;17:574-85. [PMID: 26297435 DOI: 10.1016/j.neo.2015.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Ashrafizadeh M, Hushmandi K, Hashemi M, Akbari ME, Kubatka P, Raei M, Koklesova L, Shahinozzaman M, Mohammadinejad R, Najafi M, Sethi G, Kumar AP, Zarrabi A. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Biomolecules 2020;10:E1159. [PMID: 32784711 DOI: 10.3390/biom10081159] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
25 Dang TT, Esparza MA, Maine EA, Westcott JM, Pearson GW. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program. Cancer Res 2015;75:3925-35. [PMID: 26292362 DOI: 10.1158/0008-5472.CAN-14-3363] [Cited by in Crossref: 54] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
26 Moses MA, George AL, Sakakibara N, Mahmood K, Ponnamperuma RM, King KE, Weinberg WC. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis. Int J Mol Sci 2019;20:E3590. [PMID: 31340447 DOI: 10.3390/ijms20143590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
27 Xie C, Zhu J, Huang C, Yang X, Wang X, Meng Y, Geng S, Wu J, Shen H, Hu Z, Meng Z, Li X, Zhong C. Interleukin-17A mediates tobacco smoke-induced lung cancer epithelial-mesenchymal transition through transcriptional regulation of ΔNp63α on miR-19. Cell Biol Toxicol 2021. [PMID: 33811578 DOI: 10.1007/s10565-021-09594-0] [Reference Citation Analysis]
28 Briem E, Ingthorsson S, Traustadottir GA, Hilmarsdottir B, Gudjonsson T. Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture. J Mammary Gland Biol Neoplasia 2019;24:139-47. [PMID: 30684066 DOI: 10.1007/s10911-018-09424-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Chen DJ, Chen W, Jiang H, Yang H, Wang YC, Chen JH. Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition. Drug Des Devel Ther 2016;10:2845-53. [PMID: 27660415 DOI: 10.2147/DDDT.S101998] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
30 Bortoluzzi S, Lovisa F, Gaffo E, Mussolin L. Small RNAs in Circulating Exosomes of Cancer Patients: A Minireview. High Throughput 2017;6:E13. [PMID: 29485611 DOI: 10.3390/ht6040013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
31 Bui NHB, Napoli M, Davis AJ, Abbas HA, Rajapakshe K, Coarfa C, Flores ER. Spatiotemporal Regulation of ΔNp63 by TGFβ-Regulated miRNAs Is Essential for Cancer Metastasis. Cancer Res 2020;80:2833-47. [PMID: 32312834 DOI: 10.1158/0008-5472.CAN-19-2733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Sakaram S, Craig MP, Hill NT, Aljagthmi A, Garrido C, Paliy O, Bottomley M, Raymer M, Kadakia MP. Identification of novel ΔNp63α-regulated miRNAs using an optimized small RNA-Seq analysis pipeline. Sci Rep 2018;8:10069. [PMID: 29968742 DOI: 10.1038/s41598-018-28168-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Jia D, George JT, Tripathi SC, Kundnani DL, Lu M, Hanash SM, Onuchic JN, Jolly MK, Levine H. Testing the gene expression classification of the EMT spectrum. Phys Biol 2019;16:025002. [PMID: 30557866 DOI: 10.1088/1478-3975/aaf8d4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
34 McConkey DJ, Choi W, Ochoa A, Dinney CPN. Intrinsic subtypes and bladder cancer metastasis. Asian J Urol 2016;3:260-7. [PMID: 29264194 DOI: 10.1016/j.ajur.2016.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
35 Yoh KE, Regunath K, Guzman A, Lee SM, Pfister NT, Akanni O, Kaufman LJ, Prives C, Prywes R. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells. Proc Natl Acad Sci U S A 2016;113:E6107-16. [PMID: 27681615 DOI: 10.1073/pnas.1613417113] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
36 Hashiguchi Y, Kawano S, Goto Y, Yasuda K, Kaneko N, Sakamoto T, Matsubara R, Jinno T, Maruse Y, Tanaka H, Morioka M, Hattori T, Tanaka S, Kiyoshima T, Nakamura S. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2. J Cell Physiol 2018;233:6565-77. [PMID: 29150940 DOI: 10.1002/jcp.26267] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
37 Xie C, Zhu J, Jiang Y, Chen J, Wang X, Geng S, Wu J, Zhong C, Li X, Meng Z. Sulforaphane Inhibits the Acquisition of Tobacco Smoke-Induced Lung Cancer Stem Cell-Like Properties via the IL-6/ΔNp63α/Notch Axis. Theranostics 2019;9:4827-40. [PMID: 31367260 DOI: 10.7150/thno.33812] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
38 Torres A, Alshalalfa M, Davicioni E, Gupta A, Yegnasubramanian S, Wheelan SJ, Epstein JI, De Marzo AM, Lotan TL. ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63. Prostate 2018;78:896-904. [PMID: 29761525 DOI: 10.1002/pros.23646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
39 Tian B, Li X, Kalita M, Widen SG, Yang J, Bhavnani SK, Dang B, Kudlicki A, Sinha M, Kong F, Wood TG, Luxon BA, Brasier AR. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition. BMC Genomics 2015;16:529. [PMID: 26187636 DOI: 10.1186/s12864-015-1707-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
40 Dang TT, Westcott JM, Maine EA, Kanchwala M, Xing C, Pearson GW. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion. Oncotarget 2016;7:28592-611. [PMID: 27081041 DOI: 10.18632/oncotarget.8696] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
41 Höhn A, Krüger K, Skowron MA, Bormann S, Schumacher L, Schulz WA, Hoffmann MJ, Niegisch G, Fritz G. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells. Oncotarget 2016;7:41320-35. [PMID: 27191498 DOI: 10.18632/oncotarget.9321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
42 Ferrari E, Gandellini P. Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms. Cell Death Dis 2020;11:980. [PMID: 33191398 DOI: 10.1038/s41419-020-03192-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
43 Wilhide ME, Feller JD, Li B, Mohamed AZ, Becknell B, Jackson AR, McHugh KM, Ingraham SE. Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy. Pediatr Res 2016;80:602-9. [PMID: 27384406 DOI: 10.1038/pr.2016.121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
44 De Cola A, Volpe S, Budani MC, Ferracin M, Lattanzio R, Turdo A, D'Agostino D, Capone E, Stassi G, Todaro M, Di Ilio C, Sala G, Piantelli M, Negrini M, Veronese A, De Laurenzi V. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell Death Dis 2015;6:e1823. [PMID: 26181203 DOI: 10.1038/cddis.2015.192] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
45 Hu L, Liang S, Chen H, Lv T, Wu J, Chen D, Wu M, Sun S, Zhang H, You H, Ji H, Zhang Y, Bergholz J, Xiao ZJ. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis. Proc Natl Acad Sci U S A 2017;114:E3964-73. [PMID: 28468801 DOI: 10.1073/pnas.1617816114] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
46 Papadimitriou MA, Avgeris M, Levis PK, Tokas T, Stravodimos K, Scorilas A. ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression. J Cancer Res Clin Oncol 2019;145:3075-87. [PMID: 31595333 DOI: 10.1007/s00432-019-03028-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Orzol P, Nekulova M, Holcakova J, Muller P, Votesek B, Coates PJ. ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer. Tumour Biol 2016;37:10133-40. [PMID: 26825981 DOI: 10.1007/s13277-016-4880-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
48 Kouwenhoven EN, Oti M, Niehues H, van Heeringen SJ, Schalkwijk J, Stunnenberg HG, van Bokhoven H, Zhou H. Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation. EMBO Rep 2015;16:863-78. [PMID: 26034101 DOI: 10.15252/embr.201439941] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 12.3] [Reference Citation Analysis]
49 Pflaum J, Schlosser S, Müller M. p53 Family and Cellular Stress Responses in Cancer. Front Oncol 2014;4:285. [PMID: 25374842 DOI: 10.3389/fonc.2014.00285] [Cited by in Crossref: 145] [Cited by in F6Publishing: 146] [Article Influence: 18.1] [Reference Citation Analysis]
50 Ratovitski EA. Tumor Protein p63/microRNA Network in Epithelial Cancer Cells. Curr Genomics 2013;14:441-52. [PMID: 24396276 DOI: 10.2174/13892029113146660011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
51 Lin C, Li X, Zhang Y, Guo Y, Zhou J, Gao K, Dai J, Hu G, Lv L, Du J, Zhang Y. The microRNA feedback regulation of p63 in cancer progression. Oncotarget 2015;6:8434-53. [PMID: 25726529 DOI: 10.18632/oncotarget.3020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
52 Alshammari ES, Aljagthmi AA, Stacy AJ, Bottomley M, Shamma HN, Kadakia MP, Long W. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers. BMC Cancer 2021;21:155. [PMID: 33579235 DOI: 10.1186/s12885-021-07866-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Dip N, Reis ST, Viana NI, Morais DR, Moura CM, Katz B, Abe DK, Iscaife A, Silva IA, Srougi M, Leite KR. MiRNA in bladder carcinogenesis: A review. World J Clin Urol 2014; 3(3): 238-248 [DOI: 10.5410/wjcu.v3.i3.238] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
54 Zhuang Z, Xie N, Hu J, Yu P, Wang C, Hu X, Han X, Hou J, Huang H, Liu X. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma. Oncotarget 2017;8:21954-73. [PMID: 28423539 DOI: 10.18632/oncotarget.15752] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
55 Zhao W, Wang H, Han X, Ma J, Zhou Y, Chen Z, Zhou H, Xu H, Sun Z, Kong B, Fang H. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Tumour Biol 2016;37:10621-32. [PMID: 26864590 DOI: 10.1007/s13277-016-4921-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
56 Aljagthmi AA, Hill NT, Cooke M, Kazanietz MG, Abba MC, Long W, Kadakia MP. ΔNp63α suppresses cells invasion by downregulating PKCγ/Rac1 signaling through miR-320a. Cell Death Dis 2019;10:680. [PMID: 31515469 DOI: 10.1038/s41419-019-1921-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
57 Napoli M, Flores ER. The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer. RNA Biol 2020;17:1636-47. [PMID: 31910062 DOI: 10.1080/15476286.2019.1710054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Stacy AJ, Craig MP, Sakaram S, Kadakia M. ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition. Oncotarget 2017;8:2114-29. [PMID: 27924063 DOI: 10.18632/oncotarget.13797] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
59 Fang Z, Dai W, Wang X, Chen W, Shen C, Ye G, Li L. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer. Tumour Biol 2016;37:8075-82. [PMID: 26715266 DOI: 10.1007/s13277-015-4698-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
60 de Melo Maia B, Rodrigues IS, Akagi EM, Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget 2016;7:49217-31. [PMID: 27359057 DOI: 10.18632/oncotarget.10247] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
61 Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11:25. [PMID: 30744689 DOI: 10.1186/s13148-018-0587-8] [Cited by in Crossref: 146] [Cited by in F6Publishing: 149] [Article Influence: 48.7] [Reference Citation Analysis]
62 Kobayashi T. Understanding the biology of urothelial cancer metastasis. Asian J Urol 2016;3:211-22. [PMID: 29264189 DOI: 10.1016/j.ajur.2016.09.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
63 Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE 3rd, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer. Cell Rep 2019;27:1781-1793.e4. [PMID: 31067463 DOI: 10.1016/j.celrep.2019.04.048] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 20.0] [Reference Citation Analysis]
64 Yoh K, Prywes R. Pathway Regulation of p63, a Director of Epithelial Cell Fate. Front Endocrinol (Lausanne) 2015;6:51. [PMID: 25972840 DOI: 10.3389/fendo.2015.00051] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
65 Hofbauer S, Kalogirou C, Roghmann F, Seitz AK, Vallo S, Wezel F, Worst T, Nawroth R. [Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics]. Urologe A 2017;56:202-7. [PMID: 27604705 DOI: 10.1007/s00120-016-0217-z] [Reference Citation Analysis]
66 Bornachea O, López-Calderón FF, Dueñas M, Segrelles C, Lorz C, Suárez-Cabrera C, Marañón M, Paradela-Dobarro B, Santos M, Paramio JM. The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior. Oncotarget 2015;6:24230-45. [PMID: 26203771 DOI: 10.18632/oncotarget.4353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
67 Yue PY, Ha WY, Lau CC, Cheung FM, Lee AW, Ng WT, Ngan RK, Yau CC, Kwong DL, Lung HL, Mak NK, Lung ML, Wong RN. MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma. Sci Rep 2017;7:12012. [PMID: 28931826 DOI: 10.1038/s41598-017-10695-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
68 Fishwick C, Higgins J, Percival-Alwyn L, Hustler A, Pearson J, Bastkowski S, Moxon S, Swarbreck D, Greenman CD, Southgate J. Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium. Cell Death Differ 2017;24:809-18. [PMID: 28282036 DOI: 10.1038/cdd.2017.10] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
69 Liu Y, Zhang P, Wu Q, Fang H, Wang Y, Xiao Y, Cong M, Wang T, He Y, Ma C, Tian P, Liang Y, Qin LX, Yang Q, Yang Q, Liao L, Hu G. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63. Nat Commun 2021;12:5232. [PMID: 34475402 DOI: 10.1038/s41467-021-25552-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]